Merck KGaA opens BioReliance Biodevelopment Center in Shanghai

The center offers competencies and services for bioprocess development, e. g., for the development of cell lines, and upstream and downstream processes. Target customers are SMEs in the Asia-Pacific region which work on clinical studies in an early phase. China Bio...

China’s vaccine industry: 64 kinds, 25 billion Yuan sales

China implemented a child immunization program in 1978 which is steadily expanding. In early 2017, there were 43 approved vaccine companies, accounting for 40% of the global vaccine production enterprises. About 300 companies are involved in vaccine R&D,...

China plans to complete National Technology Transfer System by 2025

The State Council will establish, by 2020, a national technology transfer system with the objective to support China’s efforts to become a leading power in science and technology. Key feature is a more unified and open technology market and exchange network on...